Santoro C, Volpicelli P, Baldacci E, Ferrara G, Di Rocco A, Ferretti A, Porrazzo M, Mazzucconi MG. Repeated successful use of eltrombopag in chronic primary immune thrombocytopenia: description of an intriguing case.
Clin Case Rep 2017;
5:1385-1388. [PMID:
28781864 PMCID:
PMC5538052 DOI:
10.1002/ccr3.920]
[Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/14/2016] [Revised: 02/21/2017] [Accepted: 02/22/2017] [Indexed: 11/21/2022] Open
Abstract
Thrombopoietin receptor agonists (TPO‐RAs) are used as effective alternative treatments in ITP patients unresponsive to first‐/second‐line therapies. TPO‐RAs can also be used to normalize platelet count to safely perform invasive procedures and chemotherapy, in case of malignancies. In few responsive patients, TPO‐RAs can be suspended maintaining a sustained response.
Collapse